During the past grant cycle, the Masonic Cancer Center (MCC) used developmental funds to support the following activities: ? 13 newly recruited investigators ? Pilot Projects: several MCC pilot mechanisms provide funding to aid in the development of multi-investigator research.
The aim i s to develop competitive applications to submit to the National Cancer Institute's Specialized Programs of Research Excellence (SPOREs), Program Project (P01), or similar grant programs ? Clinical Pharmacology Developing Shared Resource, which has become an established shared resource in this submission ? Translational Methodologies support enabled Dr. Gunda Georg, Director of the Institute for Therapeutics Discovery &Development, to generate a triptolide derivative (termed Minnelide) and to optimize its pharmacokinetic properties for use as a cancer therapeutic. Recent work demonstrated the efficacy of this drug in vivo. Minnelide has been licensed to Minneamrita Therapeutics LLC for production and will be in a clinical phase I trial in the first half of 2013 The MCC is proposing to use developmental funds for the following purposes in the upcoming funding period: ? Newly recruited faculty ? Pilot research ? Two developing shared resources o Recruitment and Retention: This shared resource will support investigators in developing recruitment plans for therapeutic and non-therapeutic studies and ensuring complete and timely enrollment of participants. o Genome Engineering: This shared resource will use recombinant adeno-associated virus (rAAV) and transcription activator-like effector nucleases (TALENs) to make site-specific alterations in human cell lines ofthe investigator's choosing. ? Staff Investigator: We are requesting funding for a 10% time Research Staff Investigator who will be responsible for developing the Cancer Detection, Treatment, and Survivorship (CaDeTS) component of the Prevention and Etiology Program to address a range of issues relevant to cancer patients and their families, including early detection through screening programs, comparative effectiveness and quality of cancer care across the continuum of care, and long-term quality-of-life outcomes of cancer survivors

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
United States
Zip Code
Pierpont, Elizabeth I; Hudock, Rebekah L; Foy, Allison M et al. (2018) Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1. J Neurodev Disord 10:21
Carlson, Erik S; Upadhyaya, Pramod; Villalta, Peter W et al. (2018) Analysis and Identification of 2'-Deoxyadenosine-Derived Adducts in Lung and Liver DNA of F-344 Rats Treated with the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of its Metabolite 4-(Methylnitrosamino)-1-(3-p Chem Res Toxicol 31:358-370
Lin, Lifeng; Chu, Haitao; Murad, Mohammad Hassan et al. (2018) Empirical Comparison of Publication Bias Tests in Meta-Analysis. J Gen Intern Med 33:1260-1267
Rashidi, Armin; Ebadi, Maryam; Said, Bassil et al. (2018) Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect. Am J Hematol :
Bejanyan, Nelli; Brunstein, Claudio G; Cao, Qing et al. (2018) Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD. Blood Adv 2:909-922
Bachanova, Veronika; Sarhan, Dhifaf; DeFor, Todd E et al. (2018) Haploidentical natural killer cells induce remissions in non-Hodgkin lymphoma patients with low levels of immune-suppressor cells. Cancer Immunol Immunother 67:483-494
Hupp, Meghan; Williams, Sarah; Dunnette, Brian et al. (2018) Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas. Hum Pathol :
Rashidi, Armin; Shanley, Ryan; Holtan, Shernan G et al. (2018) Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease. Biol Blood Marrow Transplant 24:2190-2196
Ma, Bin; Zarth, Adam T; Carlson, Erik S et al. (2018) Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 31:48-57
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891

Showing the most recent 10 out of 1013 publications